Malthus, great pickup. Obviously the Japanese technology and MSB technology are a world apart. The adult setting is the "doable" side of stem cells for the better part of the next decade or so. The Japanese research needs more review, it is, importantly, not yet considered absolutely flawed, but is being seriously questioned - hopefully, given time, it will be better understood.
Malthus, great pickup. Obviously the Japanese technology and MSB...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| $1.46 | $1.49 | $1.44 | $3.472M | 2.379M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12398 | $1.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.47 | 5440 | 3 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |